Page last updated: 2024-08-21

quinazolines and masoprocol

quinazolines has been researched along with masoprocol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allan, G; Campbell, MJ; Goldfine, ID; Hodges, L; Kerner, JA; Kushner, P; Maddux, BA; Shiry, L; Youngren, JF; Zavodovskaya, M	1
Badimon, JJ; Bauriedel, G; Huber, K; Hutter, R; Kastl, SP; Katsaros, KM; Kaun, C; Maurer, G; Speidl, WS; Wojta, J	1

Other Studies

2 other study(ies) available for quinazolines and masoprocol

Article	Year
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Journal of cellular biochemistry, 2008, Feb-01, Volume: 103, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gefitinib; Humans; Insulin-Like Growth Factor Binding Protein 3; Masoprocol; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Quinazolines; Receptor, ErbB-2; Receptor, IGF Type 1; Selective Estrogen Receptor Modulators; Tamoxifen	2008
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:1 Topics: Cells, Cultured; Complement C5a; Coronary Vessels; Fluorescent Antibody Technique; Gene Expression; Humans; Immunohistochemistry; Macrophages; Masoprocol; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Quinazolines; Receptor, Anaphylatoxin C5a; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1	2011

Article

Year

Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.

Journal of cellular biochemistry, 2008, Feb-01, Volume: 103, Issue:2

Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gefitinib; Humans; Insulin-Like Growth Factor Binding Protein 3; Masoprocol; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Quinazolines; Receptor, ErbB-2; Receptor, IGF Type 1; Selective Estrogen Receptor Modulators; Tamoxifen

2008

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:1

Topics: Cells, Cultured; Complement C5a; Coronary Vessels; Fluorescent Antibody Technique; Gene Expression; Humans; Immunohistochemistry; Macrophages; Masoprocol; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Quinazolines; Receptor, Anaphylatoxin C5a; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1

2011